- Where is SAGE Therapeutics' corporate headquarters?
- SAGE Therapeutics is headquartered at 215 First Street, Cambridge, MA 02142. The main phone number is 617-299-8380.
- When was SAGE Therapeutics founded?
- SAGE was incorporated in 2010 in the state of Delaware.
- How is SAGE Therapeutics' stock traded?
- SAGE Therapeutics is traded on the NASDAQ Global Market under the ticker symbol SAGE and its CUSIP number is 78667J 108.
- When did SAGE Therapeutics go public?
- SAGE Therapeutics’ initial public offering (IPO) occurred on July 18, 2014
- When is SAGE Therapeutics' fiscal year-end?
- December 31st.
- Who is SAGE Therapeutics' transfer agent?
P.O. Box 505000
Louisville, KY 40233
- Does SAGE Therapeutics have a direct stock purchase plan?
- SAGE Therapeutics does not have a direct stock purchase plan. Shares can be purchased through a stockbroker of your choice.
- Who are SAGE Therapeutics' independent auditors?
- PricewaterhouseCoopers LLP
101 Seaport Boulevard, Suite 500
Boston, MA 02110
- Where can I view SAGE Therapeutics' corporate news releases?
- The SAGE Therapeutics press release archives can be accessed at https://5556552.nasdaq.acsitefactory.com/press-releases
- Where can I view documents that SAGE Therapeutics has filed with the Securities & Exchange Commission (SEC)?
- The SAGE Therapeutics SEC filings can be accessed at https://5556552.nasdaq.acsitefactory.com/sec-filings or www.sec.gov.
- Whom should I contact if I have further questions?
- You can submit queries to SAGE Therapeutics’ investor relations department by contacting email@example.com or 617-299-8380.